Literature DB >> 10427134

The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines.

D K Tsang1, D L Crowe.   

Abstract

Growth factor receptors of the tyrosine kinase family regulate proliferation and migration of a variety of cell types. Binding of cognate ligands to these receptors induces multiple cellular responses, including cell cycle progression and motility in culture model systems. In stratified squamous epithelial cells, these receptors include epidermal growth factor receptor (EGFR) that binds both EGF and transforming growth factor alpha (TGFalpha), and c-met whose ligand is hepatocyte growth factor/scatter factor (HGF/SF). Intracellular signaling via these receptors occurs by several mechanisms, including activation of ras, phosphatidylinositol 3-kinase (PI3K), and the mitogen activated protein kinase (MAPK) pathways. Growth factor independence is a characteristic feature of transformation in cancer cells. Previous studies have shown that human squamous cell carcinoma (SCC) lines do not require EGF or TGFalpha for proliferation. We show that while these cell lines expressed EGFR and c-met, stimulation with their respective ligands did not induce proliferation but markedly increased invasion of reconstituted basement membranes. However, EGFR kinase activity was required for proliferation and EGF induced invasion by these cells. Signaling via ras, PI3K, and MAPK was required for proliferation of SCC lines. However, inhibition of ras and MAPK did not significantly reduce invasion by these cells nor completely block stimulation of this activity by EGF and HGF. We concluded that MAPK signaling was required for proliferation but not invasion of human SCC lines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10427134

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.

Authors:  Caren V Lund; Mikhail Popkov; Laurent Magnenat; Carlos F Barbas
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  Regulation of ERK1 gene expression by coactivator proteins.

Authors:  Beanca Y Chu; Kim Tran; Tony K S Ku; David L Crowe
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

3.  Telomere dysfunction promotes metastasis in a TERC null mouse model of head and neck cancer.

Authors:  Bojana Bojovic; David L Crowe
Journal:  Mol Cancer Res       Date:  2011-05-18       Impact factor: 5.852

4.  Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Toshinori Bito; Nahoko Sumita; Masashi Ashida; Arief Budiyanto; Masato Ueda; Masamitsu Ichihashi; Yoshiki Tokura; Chikako Nishigori
Journal:  J Skin Cancer       Date:  2010-12-08

5.  Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel.

Authors:  Jong Hyun Lee; Chulwon Kim; Gautam Sethi; Kwang Seok Ahn
Journal:  Oncotarget       Date:  2015-03-20

6.  An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine.

Authors:  Yin Liu; Teng Fei; Xiaoqi Zheng; Myles Brown; Peng Zhang; X Shirley Liu; Haiyun Wang
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

7.  Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.

Authors:  Liesbeth Hameetman; Suzan Commandeur; Jan Nico Bouwes Bavinck; Hermina C Wisgerhof; Frank R de Gruijl; Rein Willemze; Leon Mullenders; Cornelis P Tensen; Harry Vrieling
Journal:  BMC Cancer       Date:  2013-02-05       Impact factor: 4.430

8.  Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.

Authors:  David L Crowe; Arthur Ohannessian
Journal:  BMC Cancer       Date:  2004-05-07       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.